Global Complicated Urinary Tract Infection Treatment Market 2025–2029: Unveiling Growth Developments with the Latest Updates
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Complicated Urinary Tract Infection Treatment Market Be Worth By 2029?
The market size for treating complex urinary tract infections has seen robust growth in recent years. The expansion is forecast to continue, with market size increasing from $8.87 billion in 2024 to $9.44 billion in 2025, a compound annual growth rate (CAGR) of 6.4%. Factors contributing to growth in the past include the heightened frequency of urinary tract infections, a surge in antibiotic resistance, an expanding aged population, higher hospitalization rates, and increased awareness of UTIs.
Expectations for the complex urinary tract infection treatment market predict robust development in the coming years. The market is projected to expand to $12.03 billion at a compound annual growth rate (CAGR) of 6.2% by 2029. Factors leading to this rise during the forecast period include increasing encounters with multidrug-resistant pathogens, a heightened focus on precision medicine, boosted healthcare spending, expanded use of fast diagnostic tests, governmental support, and provision of research funds. Over the projected period, key trends will include progress in diagnostic methodology, expanded healthcare reach in growing markets, the creation of innovative antibiotics, technological enhancement of diagnostic equipment, and the utilization of combination therapies.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21156&type=smp
What Market Forces Are Contributing To The Growth Of The Complicated Urinary Tract Infection Treatment Market?
The increase in chronic kidney diseases is anticipated to boost the progression of the complicated urinary tract infection treatment market. Chronic kidney disease (CKD) is a prolonged ailment involving the gradual decline of kidney function over an extended period. The escalating rates of chronic kidney disease (CKD) are mainly attributed to the rising prevalences of diabetes and hypertension, coupled with aging populations and lifestyle concerns like obesity and smoking. Treatment for complicated urinary tract infections aids patients with chronic kidney disease (CKD) by warding off severe infections, like pyelonephritis, which can intensify kidney damage, deteriorate renal function, and fast track the development of chronic kidney disease, thus minimizing the prospects of additional complications and hospital stays. As an illustration, in December 2024, the Australian Institute of Health and Welfare reported that chronic kidney disease caused approximately 21,800 deaths in Australia in 2022. Additionally, in May 2024, the Kidney Care UK revealed that each year, there are between 40-45,000 premature deaths in the UK as a result of chronic kidney disease. Accordingly, the escalating rates of chronic kidney diseases fuel the growth of the complicated urinary tract infection treatment market.
Which Segments Define The Structure Of The Complicated Urinary Tract Infection Treatment Market?
The complicated urinary tract infection treatmentmarket covered in this report is segmented –
1) By Drug Class: Penicillin And combinations; Quinolones; Cephalosporin; Azoles And Amphotericin B; Nitro furans
2) By Distribution Channel: Hospital Pharmacies; Gynecology And Urology Clinics; Drug stores
3) By Application: Urethritis; Cystitis; Pyelonephritis
Subsegments:
1) By Penicillin And Combinations: Aminopenicillins; Beta-Lactamase Inhibitor Combinations
2) By Quinolones: Fluoroquinolones; Non-Fluoroquinolones
3) By Cephalosporin: First-Generation Cephalosporins; Second-Generation Cephalosporins; Third-Generation Cephalosporins; Fourth-Generation Cephalosporins; Fifth-Generation Cephalosporins
4) By Azoles And Amphotericin B: Triazoles; Imidazoles; Polyene Antifungals
5) By Nitrofurans: Nitrofurantoin; Furazolidone
What Strategic Shifts And Innovations Are Influencing The Complicated Urinary Tract Infection Treatment Market?
Leading firms in the advanced urinary tract infection treatment sector are channeling their efforts towards the development of innovative antibiotics to strengthen treatment effectiveness and tackle evolving multidrug-resistant pathogens. The use of specific antibiotics or antimicrobials forms the core of anti-infective treatments for complex urinary tract infections, especially in extreme cases involving the kidneys. For example, Allecra Therapeutics, a biopharmaceutical company based in Germany, received approval from the U.S. Food and Drug Administration (FDA) for the use of EXBLIFEP (cefepime/enmetazobactam) in treating adult complicated urinary tract infections (cUTIs) in February 2024. The organization also earned a five-year extension for marketing exclusivity under the GAIN Act, a policy that encourages the creation of new anti-infective therapies. The conducted study showed that cefepime/enmetazobactam successfully treated 79.1% of patients (a combined response of clinical cure and microbiological elimination) compared to 58.9% successfully treated with piperacillin/tazobactam.
Which Firms Are Making The Biggest Impact In The Complicated Urinary Tract Infection Treatment Market?
Major companies operating in the complicated urinary tract infection treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., AstraZeneca PLC, Fresenius Kabi AG, GlaxoSmithKline plc, bioMérieux SA, Shionogi & Co. Ltd., Cipla Limited, Santen Pharmaceutical Co. Ltd., Orchid Pharma Limited, Melinta Therapeutics Inc., Spero Therapeutics Inc., Nabriva Therapeutics AG, Venatorx Pharmaceuticals Inc., Recce Pharmaceuticals Ltd, MerLion Pharmaceuticals Pte. Ltd., Entasis Therapeutics Holdings Inc., Allecra Therapeutics GmbH, Allergan Inc.
Access The Complete Report Here:
Which Region Is Forecasted To Lead The Complicated Urinary Tract Infection Treatment Market In The Coming Years?
North America was the largest region in the complicated urinary tract infection treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the complicated urinary tract infection treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=21156&type=smp
Browse Through More Reports Similar to the Global Complicated Urinary Tract Infection Treatment Market 2025, By The Business Research Company
Urinary Incontinence And Pelvic Organ Prolapse Devices And Equipment Global Market Report 2025
Urinary Stone Treatment Devices And Equipment Global Market Report 2025
Genito Urinary Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
